Advanced or metastatic gastric cancer in elderly patients: Clinicopathological, prognostic factors and treatments

Clinical and Translational Oncology

Volumn 15, Issue 5, 2013, Pages 376-383

  Lu, Z ^a   Lu, M ^a   Zhang, X ^a   Li, J ^a   Zhou, J ^a   Gong, J ^a   Gao, J ^a   Li, Y ^a   Shen, L ^a  

^a CANCER HOSPITAL   (China)

Author keywords

Chemotherapy; Elderly; Gastric cancer; Survival

Indexed keywords

CAPECITABINE; CARCINOEMBRYONIC ANTIGEN; CISPLATIN; LACTATE DEHYDROGENASE; OXALIPLATIN; PACLITAXEL; ANTINEOPLASTIC AGENT;

ADVANCED CANCER; AGED; ARTICLE; ASCITES; BODY MASS; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; FEMALE; FOLLOW UP; GASTRECTOMY; GERIATRIC PATIENT; HUMAN; KARNOFSKY PERFORMANCE STATUS; LACTATE DEHYDROGENASE BLOOD LEVEL; LOCAL THERAPY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; STOMACH CANCER; TUMOR DIFFERENTIATION; BLOOD; MORTALITY; PATHOLOGY; PROGNOSIS; STOMACH TUMOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; FEMALE; HUMANS; L-LACTATE DEHYDROGENASE; MALE; NEOPLASM METASTASIS; PROGNOSIS; STOMACH NEOPLASMS;

EID: 84887396889     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-012-0938-4     Document Type: Article

References (30)

1. Munoz N, Franceschi S (1997) Epidemiology of gastric cancer and perspectives for prevention. Salud Publica Mex 39: 318-330
2. Kamangar F, Dores GM, Anderson WF (2006) Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24: 2137-2150
3. Bruckner HW, Morris JC, Mansfield P (2000) Neoplasms of the stomach. In: Cancer medicine, 5th edn. BC Decker, Hamilton, pp 1355-1390
4. Wu CX, Zheng Y, Bao PP et al (2008) Pattern of changing incidence of gastric cancer and its time trend in Shanghai. J Surg Concerpts Pract 13: 24-29
5. Arai T, Takubo K (2007) Clinicopathological and molecular characteristics of gastric and colorectal carcinomas in the elderly. Pathol Int 57: 303-314
6. Cascinu S, Labianca R, Alessandroni P et al (1997) Intensive weekly chemotherapy for advanced gastric cancer using fluorouracil, cisplatin, epi-doxorubicin, 6S-leucovorin, glutathione, and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer. J Clin Oncol 15: 3313-3319
7. Cascinu S, Scartozzi M, Labianca R et al (2004) High curative resection rate with weekly cisplatin, 5-fluorouracil, epidoxorubicin, 6S-leucovorin, glutathione, and filgastrim in patients with locally advanced, unresectable gastric cancer: a report from the Italian Group for the Study of Digestive Tract Cancer [GISCAD]. Br J Cancer 8: 1521-1525
8. Habu H, Endo M (1989) Gastric cancer in elderly patients: results of surgical treatment. Hepatogastroenterology 36: 71-74
9. Fujimoto S, Takahashi M, Ohkubo H et al (1994) Comparative clinicopathologic features of early gastric cancer in young and older patients. Surgery 115: 516-520
10. Wang JY, Hsieh JS, Huang CJ et al (1996) Clinicopathologic study of advanced gastric cancer without serosal invasion in young and old patients. J Surg Oncol 63: 36-40
11. Saif MW, Makrilia N, Zalonis A et al (2010) Gastric cancer in the elderly: an overview. Eur J Surg Oncol 36: 709-717
12. Arai T, Esaki Y, Inoshita N et al (2004) Pathologic characteristics of gastric cancer in the elderly: a retrospective study of 994 surgical patients. Gastric Cancer 7: 154-159
13. Ishigami S, Natsugoe S, Saihara T et al (1997) Clinical and pathologic features of early gastric cancer in elderly patients. Hepatogastroenterology 44: 1164-1168
14. Inoshita N, Yanagisawa A, Arai T et al (1998) Pathological characteristics of gastric carcinomas in the very old. Jpn J Cancer Res 89: 1087-1092
15. Wu CW, Lo SS, Shen KH et al (2000) Surgical mortality, survival and quality of life after resection for gastric cancer in the elderly. World J Surg 24: 465-472
16. Maehara Y, Emi Y, Tomisaki S et al (1996) Age-related characteristics of gastric carcinoma in young and elderly patients. Cancer 77: 1774-1780
17. Nielsen J, Aagaard J, Toftgaard C (1985) Gastric cancer with special reference to prognostic factors: a review of 779 cases. Acta Chir Scand 151: 49-55
18. Chau I, Norman AR, Cunningham D et al (2004) Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer-pooled analysis from three multicenter, randomised, controlled trials using individual patient data. J Clin Oncol 22: 2395-2403
19. Sudo H, Takagi Y, Katayanagi S et al (2006) Bone metastasis of gastric cancer. Gan To Kagaku Ryoho 33: 1058-1060
20. Glimelius B, Ekström K, Hoffman K et al (1997) Randomised comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer. Ann Oncol 8: 163-168
21. Pyrhönen S, Kuitunen T, Nyandoto P et al (1995) Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer. Br J Cancer 71: 587-591
22. Murad AM, Santiago FF, Petroianu A et al (1993) Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer. Cancer 72: 37-41
23. Trumper M, Ross PJ, Cunningham D et al (2006) Efficacy and tolerability of chemotherapy in elderly patients with advanced oesophago-gastric cancer: a pooled analysis of three clinical trials. Eur J Cancer 42: 827-834
24. Santini D, Graziano F, Catalano V et al (2006) Weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer: results of a phase II trial. BMC Cancer 6: 125
25. Graziano F, Santini D, Testa E et al (2003) A phase II study of weekly cisplatin, 6S-stereoisomer leucovorin and fluorouracil as first-line chemotherapy for elderly patients with advanced gastric cancer. Br J Cancer 89: 1428-1432
26. Koizumi W, Narahara H, Hara T et al (2008) S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol 9: 215-221
27. Seol YM, Song MK, Choi YJ et al (2009) Oral fluoropyrimidines (capecitabine or S-1) and cisplatin as first line treatment in elderly patients with advanced gastric cancer: a retrospective study. Jpn J Clin Oncol 39: 43-48
28. Tsushima T, Hironaka S, Boku N et al (2010) Safety and efficacy of S-1 monotherapy in elderly patients with advanced gastric cancer. Gastric Cancer 13: 245-250
29. Lee JL, Kang YK, Kang HJ et al (2008) A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer. Br J Cancer 99: 584-590
30. Tsuji A, Shima Y, Morita S et al (2008) Combination chemotherapy of S-1 and low-dose twice-weekly cisplatin for advanced and recurrent gastric cancer in an outpatient setting: a retrospective study. Anticancer Res 28: 1433-1438